(Q40550916)

21 September 2017

title

A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis (English)

1 reference

21 September 2017

0 references

2

1 reference

21 September 2017

15

1 reference

21 September 2017

John F Harms

1

1 reference

21 September 2017

Rajeev S Samant

3

1 reference

21 September 2017

Lalita A Shevde

4

1 reference

21 September 2017

Mary E Miele

5

1 reference

21 September 2017

Geetha R Babu

6

1 reference

21 September 2017

Steven F Goldberg

7

1 reference

21 September 2017

Virginia R Gilman

8

1 reference

21 September 2017

Donna M Sosnowski

9

1 reference

21 September 2017

Dianalee A Campo

10

1 reference

21 September 2017

Carol V Gay

11

1 reference

21 September 2017

Lynn R Budgeon

12

1 reference

21 September 2017

Robin Mercer

13

1 reference

21 September 2017

Jennifer Jewell

14

1 reference

21 September 2017

Henry J Donahue

16

1 reference

21 September 2017

Nuray Erin

17

1 reference

21 September 2017

Michael T Debies

18

1 reference

21 September 2017

William J Meehan

19

1 reference

21 September 2017

Amy L Jones

20

1 reference

21 September 2017

Gabriel Mbalaviele

21

1 reference

21 September 2017

Allen Nickols

22

1 reference

21 September 2017

Neil D Christensen

23

1 reference

21 September 2017

Robert Melly

24

1 reference

21 September 2017

Lisa N Beck

25

1 reference

21 September 2017

Julia Kent

26

1 reference

21 September 2017

Randall K Rader

27

1 reference

21 September 2017

John J Kotyk

28

1 reference

21 September 2017

M D Pagel

29

1 reference

21 September 2017

William F Westlin

30

1 reference

21 September 2017

David W Griggs

31

1 reference

21 September 2017

publication date

1 January 2004

1 reference

Clinical & Experimental Metastasis

21 September 2017

published in

1 reference

21 September 2017

volume

21

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

119-128

1 reference

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 September 2017

cites work

1 reference

12 December 2020

Breast cancer metastasis to bone: evolving models and research challenges

1 reference

12 December 2020

Association of insulin receptor substrate-1 with integrins

1 reference

12 December 2020

Maintaining GFP tissue fluorescence through bone decalcification and long-term storage

1 reference

12 December 2020

Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.

1 reference

12 December 2020

Therapeutic approaches to bone diseases

1 reference

12 December 2020

Breast tumor cell lines from pleural effusions

1 reference

12 December 2020

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo

1 reference

12 December 2020

Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line

1 reference

12 December 2020

Structure and function of RGD peptides involved in bone biology

1 reference

12 December 2020

Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization

1 reference

12 December 2020

Integrin adhesion receptors in tumor metastasis

1 reference

12 December 2020

Integrins as targets of angiogenesis inhibition

1 reference

12 December 2020

The case for early detection

1 reference

12 December 2020

The role of osteopontin in tumorigenesis and metastasis.

1 reference

12 December 2020

Osteoclast integrin alphaVbeta3 is present in the clear zone and contributes to cellular polarization

1 reference

12 December 2020

Role of stromal-derived cytokines and growth factors in bone metastasis

1 reference

12 December 2020

Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain

1 reference

12 December 2020

Signaling by integrin receptors

1 reference

12 December 2020

Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone

1 reference

12 December 2020

Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin

1 reference

12 December 2020

Ras-responsive genes and tumor metastasis

1 reference

12 December 2020

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

1 reference

12 December 2020

Further evidence to support the melanocytic origin of MDA-MB-435

1 reference

12 December 2020

Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone

1 reference

12 December 2020

Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components

1 reference

12 December 2020

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

12 December 2020

Integrin activation controls metastasis in human breast cancer

1 reference

12 December 2020

A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy

1 reference

12 December 2020

Osteopontin and colon cancer progression

1 reference

12 December 2020

The alpha v integrin antagonists as novel anticancer agents: an update

1 reference

12 December 2020

The role of the alphaVbeta3 integrin in the development of osteolytic bone metastases: a pharmacological target for alternative therapy?

1 reference

12 December 2020

MDA-MB-435 human breast carcinoma metastasis to bone

1 reference

12 December 2020

Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways

1 reference

12 December 2020

Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts.

1 reference

12 December 2020

Specialization of tumour vasculature

1 reference

12 December 2020

Involvement of chemokine receptors in breast cancer metastasis

1 reference

12 December 2020

Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice

1 reference

12 December 2020

1 reference

12 December 2020

The alpha v beta 3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor

1 reference

12 December 2020

Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone.

1 reference

12 December 2020

Mechanisms of bone metastasis

1 reference

12 December 2020

Genes involved in breast cancer metastasis to bone.

1 reference

12 December 2020

Networks and crosstalk: integrin signalling spreads.

1 reference

12 December 2020

Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF

1 reference

12 December 2020

Integrins and anoikis

1 reference

12 December 2020

Integrin alpha V beta 3 expression by bone-residing breast cancer metastases

1 reference

12 December 2020

Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength

1 reference

12 December 2020

The biochemistry of cancer dissemination

1 reference

12 December 2020

The skeleton as a unique environment for breast cancer cells

1 reference

12 December 2020

The alpha v beta 3 integrin "vitronectin receptor"

1 reference

12 December 2020

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

1 reference

12 December 2020

Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells

1 reference

12 December 2020

Oral bisphosphonates: A review of clinical use in patients with bone metastases

1 reference

12 December 2020

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

12 December 2020

Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells

1 reference

12 December 2020

10.1023/B:CLIN.0000024763.69809.64

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1040627647

0 references

1 reference